U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Viswanathan M, Kahwati LC, Golin CE, et al. Medication Therapy Management Interventions in Outpatient Settings [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Nov. (Comparative Effectiveness Reviews, No. 138.)

Cover of Medication Therapy Management Interventions in Outpatient Settings

Medication Therapy Management Interventions in Outpatient Settings [Internet].

Show details

Appendix CStudies Excluded After Full-Text Level Review

  • X1 = Ineligible Publication
  • X2 = Ineligible or No Intervention
  • X3 = Ineligible Population
  • X4 = Ineligible Study Design
  • X5 = Ineligible Comparator
  • X6 = Ineligible Outcomes
  • X7 = Ineligible Setting
  • X8 = Insufficient Information to Determine Eligibility
1.
Patients confirm that medication counseling helps. Am J Hosp Pharm. 1994 Jul 1;51(13):1606, 8. Exclusion Code: X2. [PubMed: 7942886]
2.
The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract. 2007 Apr;24(2):189–200. Exclusion Code: X2. [PubMed: 17272285]
3.
MTM program increased statin use. Dis Manag Advis. 2008 Oct;14(10) suppl 1-3:1. Exclusion Code: X1. [PubMed: 19031586]
4.
What's expected for med reconciliation? OR Manager. 2008 Mar;24(3):21, 3. Exclusion Code: X1. [PubMed: 18438074]
5.
Hospitals collaborate to reduce ED overuse. Hosp Case Manag. 2012 Oct;20(10):151–3. Exclusion Code: X1. [PubMed: 23091842]
6.
First, do no harm: avoiding medication mishaps. Johns Hopkins Med Lett Health After 50. 2013 Summer;24(6):1–4. Exclusion Code: X1. [PubMed: 24000429]
7.
Cut readmissions through med adherence. Hosp Peer Rev. 2013 Feb;38(2):19–20. Exclusion Code: X1. [PubMed: 23513301]
8.
Optimising medicines management? Drug Ther Bull. 2013 Apr;51(4):37. Exclusion Code: X1. [PubMed: 23575602]
9.
Aguiar PM, Balisa-Rocha BJ, Brito GC, et al. Pharmaceutical care in hypertensive patients: a systematic literature review (Provisional abstract). DARE. 2012;(4):383–96. Exclusion Code: X2. [PubMed: 22222348]
10.
Al-Ghamdi SA, Mahmoud MA, Alammari MA, et al. The outcome of pharmacist counseling at the time of hospital discharge: an observational nonrandomized study. Ann Saudi Med. 2012 Sep-Oct;32(5):492–7. Exclusion Code: X2. [PMC free article: PMC6080998] [PubMed: 22871618]
11.
Alsuwaidan S, Malone DC, Billups SJ, et al. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers. IMPROVE investigators. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm. 1998 Jan 1;55(1):68–72. Exclusion Code: X2. [PubMed: 9437478]
12.
Altman JS. Medication therapy management and the new practitioner. Am J Health Syst Pharm. 2007 Mar 15;64(6):590–2. Exclusion Code: X1. [PubMed: 17353567]
13.
Anonymous. Prescribing and research in medicines management (UK & Ireland) Conference 2013 Imperial Hotel London January 24th 2013 “Intelligent polypharmacy … It's not all about the number” abstract. Pharmacoepidemiol Drug Saf. 22:670. Exclusion Code: X1. [PubMed: 23576467]
14.
Armour CL, Reddel HK, LeMay KS, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013 Apr;50(3):302–9. Exclusion Code: X2. [PubMed: 23270495]
15.
Asis ML, Greene R. A cost-effectiveness analysis of a peak flow-based asthma education and self-management plan in a high-cost population. J Asthma. 2004;(5):559–65. (Structured abstract) Exclusion Code: X2. [PubMed: 15360065]
16.
Atkinson WL, Frey D. Integration of a medication management model into outcome-based quality improvement: a pilot program in a rural propriety home healthcare agency. Home Health Care Serv Q. 2005;24(1-2):29–45. Exclusion Code: X4. [PubMed: 16236657]
17.
Avery AJ, Rodgers S, Cantrill JA, et al. Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials. 2009;10:28. Exclusion Code: X2. [PMC free article: PMC2685134] [PubMed: 19409095]
18.
Avery AJ, Rodgers S, Cantrill JA, et al. Correction: Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials. 2010;23 Exclusion Code: X1. [PMC free article: PMC2685134] [PubMed: 19409095]
19.
Bandres MA, Mendoza MA, Nicolas FG, et al. Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain. :1083. Exclusion Code: X2. [PubMed: 23881347]
20.
Bates DW. Role of pharmacists in the medical home. Am J Health Syst Pharm. 2009 Jun 15;66(12):1116–8. Exclusion Code: X1. [PubMed: 19498128]
21.
Bayoumi I, Howard M, Holbrook AM, et al. Interventions to improve medication reconciliation in primary care. Ann Pharmacother. 2009;(10):1667–75. (Structured abstract) Exclusion Code: X2. [PubMed: 19737997]
22.
Bell JS, Vaananen M, Ovaskainen H, et al. Providing patient care in community pharmacies: practice and research in Finland. Ann Pharmacother. 2007 Jun;41(6):1039–46. Exclusion Code: X1. [PubMed: 17504836]
23.
Bellone JM, Barner JC, Lopez DA. Postdischarge interventions by pharmacists and impact on hospital readmission rates. J Am Pharm Assoc (2003). 2012 May-Jun;52(3):358–62. Exclusion Code: X2. [PubMed: 22618976]
24.
Bennett MI, Bagnall AM, Raine G, et al. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain. 2011 Sep;27(7):623–30. Exclusion Code: X3. [PubMed: 21610491]
25.
Benrimoj SI, Langford JH, Berry G, et al. Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance. Pharmacoeconomics. 2000 Nov;18(5):459–68. Exclusion Code: X2. [PubMed: 11151399]
26.
Bergkvist A, Midlov P, Hoglund P, et al. Improved quality in the hospital discharge summary reduces medication errors--LIMM: Landskrona Integrated Medicines Management. Eur J Clin Pharmacol. 2009 Oct;65(10):1037–46. Exclusion Code: X7. [PubMed: 19557400]
27.
Bergkvist A, Midlov P, Hoglund P, et al. A multi-intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM-Landskrona Integrated Medicines Management. J Eval Clin Pract. 2009 Aug;15(4):660–7. Exclusion Code: X7. [PubMed: 19674217]
28.
Berjis M, Ho MI, Gray DR. Evaluation of patient outcome and pharmaceutical care in an HIV clinic. ASHP Midyear Clinical Meeting. 1996;31(Dec) P-E. Exclusion Code: X6.
29.
Bertino J, Villa T, Corbett A, et al. Effects of optimal medication therapy management of depression in human immunodeficiency virus (HIV) infected patients on associated virologic and immunologic outcomes. J Pharm Pract. 2008;21(Jan):78. Exclusion Code: X2.
30.
Billups SJ, Okano G, Malone D, et al. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers. Am J Health Syst Pharm. 2000 Jan 1;57(1):29–39. Exclusion Code: X6. [PubMed: 10630554]
31.
Bilyeu KM, Gumm CJ, Fitzgerald JM, et al. Cultivating quality: Reducing the use of potentially inappropriate medications in older adults. Am J Nurs. 2011 Jan;111(1):47–52. Exclusion Code: X2. [PubMed: 21191234]
32.
Bland CM, Tritsch AM, Bookstaver DA, et al. Hypertension and diabetes mellitus medication management in sleeve gastrectomy patients. Am J Health Syst Pharm. 2013 Jun 15;70(12):1018–20. Exclusion Code: X2. [PubMed: 23719877]
33.
Blennerhassett JD, Cusack BM, Smith CD, et al. A novel medicines management pathway. J Pharm Pract Res. 2006;36(Mar):175–9. Exclusion Code: X7.
34.
Blozik E, Born AM, Stuck AE, et al. Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study. Drugs Aging. 2010 Dec 1;27(12):1009–17. Exclusion Code: X7. [PubMed: 21087070]
35.
Bonnet-Zamponi D, d'Arailh L, Konrat C, et al. Drug-related readmissions to medical units of older adults discharged from acute geriatric units: results of the Optimization of Medication in AGEd multicenter randomized controlled trial. J Am Geriatr Soc. 2013 Jan;61(1):113–21. Exclusion Code: X7. [PubMed: 23252914]
36.
Borges AP, Guidoni CM, Ferreira LD, et al. The pharmaceutical care of patients with type 2 diabetes mellitus. Pharm World Sci. 2010 Dec;32(6):730–6. Exclusion Code: X8. [PubMed: 20734138]
37.
Borges AP, Guidoni CM, Freitas O, et al. Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metabol. 2011 Dec;55(9):686–91. Exclusion Code: X8. [PubMed: 22231970]
38.
Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm. 1994 Mar 15;51(6):772–7. Exclusion Code: X4. [PubMed: 8010315]
39.
Branham AR, Katz AJ, Moose JS, et al. Retrospective Analysis of Estimated Cost Avoidance Following Pharmacist-Provided Medication Therapy Management Services. :420. Exclusion Code: X4. [PubMed: 23178415]
40.
Bratcher CR, Bello E. Traditional or centralized models of diabetes care: the multidisciplinary diabetes team approach. J Fam Pract. 2011 Nov;60(11 Suppl):S6–11. Exclusion Code: X1. [PubMed: 22336928]
41.
Brooks JM, Unni EJ, Klepser DG, et al. Factors affecting demand among older adults for medication therapy management services. Res Social Adm Pharm. 2008 Dec;4(4):309–19. Exclusion Code: X2. [PubMed: 19064238]
42.
Brown DL, Wolff DJ, Smith LD, et al. Computer-supported medication counseling for discharged patients. Am J Hosp Pharm. 1986 Sep;43(9):2232–5. Exclusion Code: X2. [PubMed: 3766581]
43.
Brown EV. Reconcilable differences. Health Manag Technol. 2008 Jan;29(1):12–4. 6. Exclusion Code: X1. [PubMed: 18286931]
44.
Brusig E, Davies W. PSTAC survey in 2006 was instrumental in obtaining permanent (category I) CPT codes for MTM services performed by pharmacists. J Manag Care Pharm. 2008 Jan-Feb;14(1):86–7. Exclusion Code: X1. [PMC free article: PMC10437828] [PubMed: 18240887]
45.
Bucci C, Jackevicius C, McFarlane K, et al. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol. 2003 Mar 31;19(4):391–6. Exclusion Code: X8. [PubMed: 12704485]
46.
Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):133–47. Exclusion Code: X2. [PubMed: 16602223]
47.
Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):23–31. Exclusion Code: X4. [PubMed: 18192127]
48.
Burnett KM, Scott MG, Fleming GF, et al. Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. Am J Health Syst Pharm. 2009 May 1;66(9):854–9. Exclusion Code: X2. [PubMed: 19386949]
49.
Butler CD. Medication therapy management for adverse drug event preventive care. J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):449. Exclusion Code: X1. [PubMed: 20621858]
50.
Cadth. Medication reconciliation at discharge: a review of the clinical evidence and guidelines. Health Technology Assessment Database. 2012;(1) (Structured abstract) Exclusion Code: X2.
51.
Cahill JA, Manasse HR Jr. Medication therapy management programs: to optimize pharmacy outcomes. J Manag Care Pharm. 2005 Mar;11(2):179. Exclusion Code: X1. [PMC free article: PMC10437770] [PubMed: 15766326]
52.
Cantwell KM. Collaborating for successful medication therapy management programs. Am J Health Syst Pharm. 2005 Mar 15;62(6):583. Exclusion Code: X1. [PubMed: 15757878]
53.
Carey N, Courtenay M, James J, et al. An evaluation of a Diabetes Specialist Nurse prescriber on the system of delivering medicines to patients with diabetes. J Clin Nurs. 2008 Jun;17(12):1635–44. Exclusion Code: X7. [PubMed: 18482124]
54.
Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009 Nov 23;169(21):1996–2002. Exclusion Code: X2. [PMC free article: PMC2882170] [PubMed: 19933962]
55.
Carter BL, Lund BC, Hayase N, et al. A longitudinal analysis of antihypertensive drug interactions in a Medicaid population. Am J Hypertens. 2004 May;17(5 Pt 1):421–7. Exclusion Code: X5. [PubMed: 15110901]
56.
Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001 Jul 15;58(14):1330–7. Exclusion Code: X1. [PubMed: 11471481]
57.
Carter BL, Malone DC, Ellis SL, et al. Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles. J Clin Hypertens (Greenwich). 2000 May;2(3):172–80. Exclusion Code: X5. [PubMed: 11416643]
58.
Carter BL, Malone DC, Valuck RJ, et al. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm. 1998 Jan 1;55(1):62–7. Exclusion Code: X6. [PubMed: 9437477]
59.
Carter BL, Zillich AJ, Elliott WJ. How pharmacists can assist physicians with controlling blood pressure. J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):31–7. Exclusion Code: X1. [PMC free article: PMC8101839] [PubMed: 12556651]
60.
Casteel C, Blalock SJ, Ferreri S, et al. Implementation of a community pharmacy-based falls prevention program. Am J Geriatr Pharmacother. 2011 Oct;9(5):310–9 e2. Exclusion Code: X2. [PubMed: 21925959]
61.
Castro R, Leung J, Song J, et al. Outcomes of implementing a medication therapy management service for dialysis patients. :056. Exclusion Code: X2.
62.
Cauchi R. Medication therapy management: catching errors, saving lives and money. NCSL Legisbrief. 2010 Jan;18(4):1–2. Exclusion Code: X1. [PubMed: 20196247]
63.
Centers for Medicare & Medicaid Services. Medicare Part D Medication Therapy Management (MTM) Programs: 2009 Fact Sheet. 2009. Exclusion Code: X4.
64.
Centers for Medicare & Medicaid Services. 2010 Medicare Part D Medication Therapy Management (MTM) Programs Fact Sheet. 2010. Exclusion Code: X4.
65.
Centers for Medicare & Medicaid Services. 2012 Medicare Part D Medication Therapy Management (MTM) Programs Fact Sheet. 2012. Exclusion Code: X4.
66.
Cestac P, Tavassoli N, Vellas B, et al. Improving medication use in the nursing homes: a European perspective. J Am Med Dir Assoc. 2013 Jan;14(1):6–9. Exclusion Code: X1. [PubMed: 23158846]
67.
Chapman NR, Fotis MA, Yarnold PR, et al. Pharmacist interventions to improve the management of coronary artery disease. Am J Health Syst Pharm. 2004 Dec 15;61(24):2672–8. Exclusion Code: X2. [PubMed: 15646702]
68.
Charrois TL, Zolezzi M, Koshman SL, et al. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012 Mar;32(3):222–33. Exclusion Code: X2. [PubMed: 22392455]
69.
Cheng Y, Raisch DW, Borrego ME, et al. Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: A literature review. :311. Exclusion Code: X2. [PubMed: 22835704]
70.
Ching MM, Chen T, Bounthavong M. Medication therapy management programs at a VA medical facility: effectson blood cholesterol in high risk patients. CA J Health-Sys Pharm. 23:15. Exclusion Code: X2.
71.
Chisholm MA, Mulloy LL, Jagadeesan M, et al. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis. 2002 Summer;12(3):392–7. Exclusion Code: X7. [PubMed: 12148711]
72.
Chisholm MA, Reinhardt BO, Vollenweider LJ, et al. Effect of pharmaceutical care services on renal transplant patients' blood glucose levels. ASHP Midyear Clinical Meeting. 1999;34(Dec) P-E. Exclusion Code: X4.
73.
Chisholm MA, Spivey CA, Mulloy LL. Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients. Am J Health Syst Pharm. 2007 Jul 15;64(14):1506–12. Exclusion Code: X5. [PubMed: 17617501]
74.
Choe HM, Mitrovich S, Dubay D, et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005 Apr;11(4):253–60. Exclusion Code: X2. [PubMed: 15839185]
75.
Christensen DB, Campbell WH, Madsen S, et al. Documenting outpatient problem intervention activities of pharmacists in an HMO. Med Care. 1981 Jan;19(1):104–17. Exclusion Code: X4. [PubMed: 7464303]
76.
Christensen DB, Holmes G, Fassett WE, et al. Principal findings from the Washington State cognitive services demonstration project. Manag Care Interface. 1998 Jul;11(7):60–2. 4. Exclusion Code: X2. [PubMed: 10181572]
77.
Cioffi ST, Caron MF, Kalus JS, et al. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother. 2004 May;38(5):771–5. Exclusion Code: X4. [PubMed: 15031417]
78.
Coast-Senior EA, Kroner BA, Kelley CL, et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998 Jun;32(6):636–41. Exclusion Code: X4. [PubMed: 9640480]
79.
Collins C, Kramer A, O'Day ME, et al. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health Syst Pharm. 2006 Sep 15;63(18):1723–7. Exclusion Code: X4. [PubMed: 16960256]
80.
Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001 Oct;21(10):1196–203. Exclusion Code: X2. [PubMed: 11601666]
81.
Cote I, Gregoire JP, Moisan J, et al. A pharmacy-based health promotion programme in hypertension: cost-benefit analysis. Pharmacoeconomics. 2003;21(6):415–28. Exclusion Code: X2. [PubMed: 12678568]
82.
Cotterell CC, Dombroske L, Fischermann EA. Comprehensive drug-use evaluation program in a health maintenance organization. Am J Hosp Pharm. 1991 Aug;48(8):1712–7. Exclusion Code: X1. [PubMed: 1897551]
83.
Couturaud F, Proust A, Frachon I, et al. Education and self-management: a one-year randomized trial in stable adult asthmatic patients. J Asthma. 2002 Sep;39(6):493–500. Exclusion Code: X2. [PubMed: 12375708]
84.
Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173–84. Exclusion Code: X4. [PubMed: 12688435]
85.
Curwain B. Hampshire medicines management project saves NHS over British pound sterling1 million. Pharm J (England). 2007;278(Feb) PM1-PM2. Exclusion Code: X2.
86.
Degnin FD. Difficult patients, overmedication, and groupthink. J Clin Ethics. 2009 Spring;20(1):64–74. Exclusion Code: X1. [PubMed: 19385324]
87.
Dersch D. Patient assessment tool for pharmacists. Am J Health Syst Pharm. 2008 Apr 15;65(8):702–3. Exclusion Code: X1. [PubMed: 18387897]
88.
Donohue JM, Zhang Y, Aiju M, et al. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatry. 2011 Dec;19(12):989–97. Exclusion Code: X2. [PMC free article: PMC3233981] [PubMed: 22123272]
89.
Doucette WR, McDonough RP, Klepser D, et al. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005 Jul;27(7):1104–11. Exclusion Code: X4. [PubMed: 16154490]
90.
Doucette WR, Witry MJ, Alkhateeb F, et al. Attitudes of Medicare beneficiaries toward pharmacist-provided medication therapy management activities as part of the Medicare Part D benefit. J Am Pharm Assoc (2003). 2007 Nov-Dec;47(6):758–62. Exclusion Code: X4. [PubMed: 18032140]
91.
Dougherty L. Medicine management and infection prevention. Br J Nurs. 2011 Jul 28-Aug 4;20(14):S3. Exclusion Code: X1. [PubMed: 21841665]
92.
Downie G, Cromarty E, Ellis G, et al. Assessment of medicine management in people ages 75 years or over living in the community in Grampian, Scotland. ASHP Midyear Clinical Meeting. 2001;36(Dec) P-E. Exclusion Code: X4.
93.
Dudas V, Bookwalter T, Kerr KM, et al. The impact of follow-up telephone calls to patients after hospitalization. Dis Mon. 2002 Apr;48(4):239–48. Exclusion Code: X2. [PubMed: 12021756]
94.
Eden M, Avery A, Rodgers S, et al. Ensuring accuracy in routinely collected data in a cluster randomised controlled trial (RCT) comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management: The PINCER Trial. Int J Pharm Pract. 2010:60–1. Exclusion Code: X1. [PMC free article: PMC2685134] [PubMed: 19409095]
95.
Elkjaer M. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance. Dan Med J. 2012 Jul;59(7):B4478. Exclusion Code: X2. [PubMed: 22759851]
96.
Elliott RA, Martinac G, Campbell S, et al. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs Aging. 2012 Jul 1;29(7):593–605. Exclusion Code: X2. [PubMed: 22715865]
97.
Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther. 2003 Oct;28(5):395–402. Exclusion Code: X2. [PubMed: 14632964]
98.
Epplen K, Dusing-Wiest M, Freedlund J, et al. Stepwise approach to implementing ambulatory clinical pharmacy services. Am J Health Syst Pharm. 2007 May 1;64(9):945–51. Exclusion Code: X2. [PubMed: 17468149]
99.
Epplen K, Marsden LM, Murphy C. Reimbursement for medication therapy management services. Am J Health Syst Pharm. 2008 May 15;65(10):906–8. Exclusion Code: X1. [PubMed: 18463337]
100.
Ermer M, Harder S. Medication review of community-dwelling seniors using intensified home-care service. Int J Clin Pharmacol Ther. 2011 Mar;49(3):179–84. Exclusion Code: X2. [PubMed: 21329619]
101.
Farris KB, Ganther-Urmie JM, Fang G, et al. Population-based medication reviews: a descriptive analysis of the medication issues identified in a medicare not-for-profit prescription discount program. Ann Pharmacother. 2004 Nov;38(11):1823–9. Exclusion Code: X2. [PubMed: 15479770]
102.
Farris KB, Kumbera P, Halterman T, et al. Outcomes-based pharmacist reimbursement: Reimbursing pharmacists for cognitive services - (Part 1 of a 2-part series). J Manag Care Pharm. 2002;8(May):383–93. Exclusion Code: X4. [PubMed: 14613406]
103.
Feldman PH, Totten AM, Foust J, et al. Medication management: evidence brief. Center for Home Care Policy & Research. Home Healthc Nurse. 2009 Jun;27(6):379–86. Exclusion Code: X1. [PubMed: 19509525]
104.
Feldman SM. Pharmaceutical care and the consultant pharmacist. A model for drug therapy management. Am Pharm. 1995 Suppl:19–21. Exclusion Code: X1. [PubMed: 7677061]
105.
Fera T, Bluml BM, Ellis WM, et al. The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program. J Am Pharm Assoc (2003). 2008 Mar-Apr;48(2):181–90. Exclusion Code: X2. [PubMed: 18359731]
106.
Figge HL. Interoperable health information exchange between medication therapy management services and the medical home. Am J Health Syst Pharm. 2010 Feb 1;67(3):190–1. Exclusion Code: X1. [PubMed: 20101060]
107.
Finley PR, Bluml BM, Bunting BA, et al. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):40–9. Exclusion Code: X2. [PubMed: 21247825]
108.
Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy. 2003 Sep;23(9):1175–85. Exclusion Code: X2. [PubMed: 14524649]
109.
Fisher JE, Zhang Y, Sketris I, et al. The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis. Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):177–83. Exclusion Code: X2. [PMC free article: PMC3747098] [PubMed: 22081471]
110.
Fletcher J, Hogg W, Farrell B, et al. Effect of nurse practitioner and pharmacist counseling on inappropriate medication use in family practice. Can Fam Physician. 2012 Aug;58(8):862–8. Exclusion Code: X2. [PMC free article: PMC3418988] [PubMed: 22893340]
111.
Forster AJ, Auger C. Using information technology to improve the monitoring of outpatient prescribing. JAMA Intern Med. 2013 Mar 11;173(5):382–4. Exclusion Code: X2. [PubMed: 23381469]
112.
Frew EJ, Kluettgens B, Gilday N, et al. The impact of a medicines management service on patients with cystic fibrosis. :686. Exclusion Code: X4.
113.
Gadzhanova SV, Roughead EE, Bartlett MJ. Improving cardiovascular disease management in Australia: NPS MedicineWise. Med J Aust. 2013 Aug 5;199(3):192–5. Exclusion Code: X5. [PubMed: 23909542]
114.
Garcao JA, Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6):858–64. Exclusion Code: X2. [PubMed: 12482009]
115.
Gardella JE, Cardwell TB, Nnadi M. Improving medication safety with accurate preadmission medication lists and postdischarge education. Jt Comm J Qual Patient Saf. 2012 Oct;38(10):452–8. Exclusion Code: X2. [PubMed: 23130391]
116.
Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc (2003). 2005 Mar-Apr;45(2):130–7. Exclusion Code: X2. [PubMed: 15868754]
117.
Garrett DG, Bluml BM. Patient self-management program for diabetes. J Pharm Soc Wis. 2005;(C):17–27. Exclusion Code: X4.
118.
Geletko SM, Poulakos MN. Pharmaceutical services in an HIV clinic. Am J Health Syst Pharm. 2002 Apr 15;59(8):709–13. Exclusion Code: X4. [PubMed: 11977854]
119.
Gerber RA, Liu G, McCombs JS. Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization. Am J Manag Care. 1998 Jul;4(7):991–1000. Exclusion Code: X2. [PubMed: 10181997]
120.
Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust. 2002 Aug 19;177(4):189–92. Exclusion Code: X4. [PubMed: 12175322]
121.
Gillespie U, Alassaad A, Hammarlund-Udenaes M, et al. Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial. PLoS One. 2013;8(5):e62401. Exclusion Code: X7. [PMC free article: PMC3656885] [PubMed: 23690938]
122.
Gizzi L, Slain D, Hare J, et al. An assessment of a pharmacy-based enhancement to the hospital medication reconciliation process. Exclusion Code: X2.
123.
Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):152–60. Exclusion Code: X2. [PubMed: 15098849]
124.
Gourley GA, Portner TS, Gourley DR, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;(5):586–97. Exclusion Code: X2. [PubMed: 9782692]
125.
Grantham D. Idaho behavioral health optimizes med management visits using telehealth. Behav Healthc. 2011 Oct;31(7):46–7. Exclusion Code: X1. [PubMed: 22117294]
126.
Griffiths M. Medicines management. Nurs Stand. 2008 Oct 1-7;23(4):28. Exclusion Code: X1. [PubMed: 19051531]
127.
Griffiths M. Medicines management. Nurs Stand. 2009 Sep 23-29;24(3):28. Exclusion Code: X1. [PubMed: 19856642]
128.
Griffiths M. Medicines management. Nurs Stand. 2010 Nov 17-23;25(11):28. Exclusion Code: X1. [PubMed: 21189818]
129.
Griffiths M. Medicines management. Clear criteria are needed for any dose adjustment. Nurs Stand. 2010 Jan 13-19;24(19):28. Exclusion Code: X1. [PubMed: 20175358]
130.
Gruffydd-Jones K, Hollinghurst S, Ward S, et al. Targeted routine asthma care in general practice using telephone triage. Br J Gen Pract. 2005;(1):918–23. (Structured abstract) Exclusion Code: X2. [PMC free article: PMC1570530] [PubMed: 16378560]
131.
Guirguis AB, Zingone MM. Medication therapy management and cost-related medication nonadherence. JAMA. 2008 Sep 10;300(10):1130. author reply -1. Exclusion Code: X1. [PubMed: 18780839]
132.
Haines LA, Putney KS, Varkey DA, et al. Pilot of a patient-centered pharmacy practice model. Am J Health Syst Pharm. 2012 Nov 1;69(21):1860–1. Exclusion Code: X5. [PubMed: 23111668]
133.
Hall D, Buchanan J, Helms B, et al. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy. 2011 Jul;31(7):686–94. Exclusion Code: X2. [PubMed: 21923456]
134.
Hall DL, Pater KS. Implementation of a Medication Therapy Management Program in a Hospital-Based Outpatient Pharmacy. :512. Exclusion Code: X4.
135.
Hallam A. Does peer review improve patient care and documentation in medication therapy management? Kaiser Permanente; pp. 1–33. Exclusion Code: X2.
136.
Hardin HC, Hall AM, Roane TE, et al. An Advanced Pharmacy Practice Experience in a Student-Staffed Medication Therapy Management Call Center. p. NIL. Exclusion Code: X4. [PMC free article: PMC3425925] [PubMed: 22919086]
137.
Harris A, Gospodarevskaya E, Callaghan J, et al. The cost effectiveness of a pharmacist reviewing medication among the elderly in the community. Australas J Ageing. 2001;20(4):179–86. Exclusion Code: X2.
138.
Harris IM, Westberg SM, Frakes MJ, et al. Outcomes of medication therapy review in a family medicine clinic. J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):623–7. Exclusion Code: X4. [PubMed: 19748869]
139.
Harrison JJ, Wang J, Cervenko J, et al. Pilot study of a pharmaceutical care intervention in an outpatient lung transplant clinic. Clin Transplant. 2012 Mar-Apr;26(2):E149–57. Exclusion Code: X7. [PubMed: 22507355]
140.
Hassol A, Shoemaker SJ. Exploratory Research on Medication Therapy Management. Baltimore, MD: Centers for Medicare & Medicaid Services; Jul 8, 2008. (Prepared by Abt Associates under Contract #HHSM-500-2005-00181/TO#3) http://www​.cms.gov/Research-Statistics-Data-and-Systems​/Statistics-Trends-and-Reports​/Reports/downloads/blackwell.pdf. Exclusion Code: X4.
141.
Hata M, Klotz R, Sylvies R, et al. Medication therapy management services provided by student pharmacists. Am J Pharm Educ. 2012 Apr 10;76(3):51. Exclusion Code: X4. [PMC free article: PMC3327249] [PubMed: 22544968]
142.
Hellstrom LM, Bondesson A, Hoglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011 Jul;67(7):741–52. Exclusion Code: X2. [PubMed: 21318595]
143.
Hemens BJ, Holbrook A, Tonkin M, et al. Computerized clinical decision support systems for drug prescribing and management: a decision-maker-researcher partnership systematic review. Implement Sci. 2011;6:89. Exclusion Code: X2. [PMC free article: PMC3179735] [PubMed: 21824383]
144.
Hilario Deguzman LF. Intervening On Hospital Discharge Patients: Results from a Medicare Part D MTM program. Kaiser Permanente; 2013. pp. 1–32. Exclusion Code: X2.
145.
Hogan EG, Leal S, Slack M, et al. Comparison of pharmacist led collaborative drug therapy management to standard physician provided therapy for type 2 diabetes mellitus. ASHP Midyear Clinical Meeting. 2005;40:P518E. Exclusion Code: X2.
146.
Holloway KA, Ivanovska V, Wagner AK, et al. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health. 2013 Jun;18(6):656–64. Exclusion Code: X2. [PubMed: 23648177]
147.
Holtorf AP, McAdam-Marx C, Schaaf D, et al. Systematic review on quality control for drug management programs: is quality reported in the literature? BMC Health Serv Res. 2009;9:38. Exclusion Code: X2. [PMC free article: PMC2653499] [PubMed: 19243591]
148.
Hong N, Jackson L, Pisupati R. Evaluation of clinical pharmacy services in an ambulatory care HIV/AIDS Clinic. :056. Exclusion Code: X4.
149.
Howard-Thompson A, Farland MZ, Byrd DC, et al. Pharmacist-Physician Collaboration for Diabetes Care: Cardiovascular Outcomes. Ann Pharmacother. 47:1471. Exclusion Code: X2. [PubMed: 24285763]
150.
Humphries TL, Carroll N, Chester EA, et al. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention. Ann Pharmacother. 2007 Dec;41(12):1979–85. Exclusion Code: X2. [PubMed: 17986517]
151.
Hunteman LM. Potential role of medication therapy management for bariatric surgery patients. J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):440–2. Exclusion Code: X1. [PubMed: 18653412]
152.
Hussein M, Benner JS, Lee D, et al. Propensity score matching in the evaluation of drug therapy management programs: an illustrative analysis of a program for patients with hepatitis C virus. Qual Manag Health Care. 2010 Jan-Mar;19(1):25–33. Exclusion Code: X2. [PubMed: 20042931]
153.
Isetts BJ. Evaluating Effectiveness of the Minnesota Medication Therapy Management Care Program: Final Report. University of Minnesota College of Pharmacy; Minneapolis, MN: 2007. Exclusion Code: X4.
154.
Isetts BJ, Brown LM, Schondelmeyer SW, et al. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003 Aug 11-25;163(15):1813–20. Exclusion Code: X4. [PubMed: 12912717]
155.
Isetts BJ, Brummel AR, de Oliveira DR, et al. Managing drug-related morbidity and mortality in the patient-centered medical home. Med Care. 2012 Nov;50(11):997–1001. Exclusion Code: X2. [PubMed: 23047790]
156.
Isetts BJ, Schondelmeyer SW, Heaton AH, et al. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm. 2006 Mar;2(1):129–42. Exclusion Code: X2. [PubMed: 17138505]
157.
Jaber LA, Halapy H, Fernet M, et al. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996 Mar;30(3):238–43. Exclusion Code: X2. [PubMed: 8833557]
158.
Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009;(3):178–87. Exclusion Code: X2. [PMC free article: PMC2738592] [PubMed: 19189907]
159.
Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008 Feb 26;117(8):1028–36. Exclusion Code: X2. [PubMed: 18299512]
160.
Jackson GL, Oddone EZ, Olsen MK, et al. Racial differences in the effect of a telephone-delivered hypertension disease management program. J Gen Intern Med. 2012 Dec;27(12):1682–9. Exclusion Code: X2. [PMC free article: PMC3509293] [PubMed: 22865016]
161.
Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001 Jul-Aug;35(7-8):835–40. Exclusion Code: X2. [PubMed: 11485129]
162.
Jayaprakash A. ASCP reports. Consult Pharm. 2010 Feb;25(2):128. Exclusion Code: X1. [PubMed: 20211826]
163.
Johnson CL, Nicholas A, Divine H, et al. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):722–30. Exclusion Code: X4. [PubMed: 19019800]
164.
Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997 Mar 1;54(5):554–8. Exclusion Code: X2. [PubMed: 9066865]
165.
Johnston AM, Doane K, Phipps S, et al. Outcomes of pharmacists' cognitive services in the long-term care setting. Consult Pharm. 1996;11:41–50. Exclusion Code: X4.
166.
Kaboli PJ, Fernandes O. Medication reconciliation: moving forward. Arch Intern Med. 2012 Jul 23;172(14):1069–70. Exclusion Code: X1. [PubMed: 22733283]
167.
Karapinar-Carkit F, Borgsteede SD, Zoer J, et al. The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients. BMC Health Serv Res. 2010;10:39. Exclusion Code: X7. [PMC free article: PMC2843699] [PubMed: 20156368]
168.
Kimberlin CL, Berardo DH, Pendergast JF, et al. Effects of an education program for community pharmacists on detecting drug-related problems in elderly patients. Med Care. 1993 May;31(5):451–68. Exclusion Code: X2. [PubMed: 8501992]
169.
Kliethermes MA. Adherence in an MTM clinic. 2009:204. Exclusion Code: X8.
170.
Klimek JS. MTM services standards improve patient safety. Medication therapy management safeguards, systems and services can reduce the total number of medication-related complications. Health Manag Technol. 2009 Jul;30(7):20–1. Exclusion Code: X1. [PubMed: 19739561]
171.
Kocarnik BM, Liu CF, Wong ES, et al. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence? BMC Health Serv Res. 2012;12:391. Exclusion Code: X2. [PMC free article: PMC3537712] [PubMed: 23148570]
172.
Krass I, Taylor SJ, Smith C, et al. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):33–40. Exclusion Code: X2. [PubMed: 15730115]
173.
Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012 Jul 3;157(1):1–10. Exclusion Code: X7. [PMC free article: PMC3575734] [PubMed: 22751755]
174.
Kucukarslan SN, Hagan AM, Shimp LA, et al. Integrating medication therapy management in the primary care medical home: A review of randomized controlled trials. Am J Health Syst Pharm. 2011 Feb 15;68(4):335–45. Exclusion Code: X6. [PubMed: 21289329]
175.
Kumbera P. A new addition to pharmacy's alphabet soup: MTMS. Pharmacy Times (USA). 2005;71(Mar):90. Exclusion Code: X1.
176.
Kuzuya M, Hirakawa Y, Suzuki Y, et al. Association between unmet needs for medication support and all-cause hospitalization in community-dwelling disabled elderly people. J Am Geriatr Soc. 2008 May;56(5):881–6. Exclusion Code: X2. [PubMed: 18384585]
177.
Kwint HF, Bermingham L, Faber A, et al. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013 Feb;30(2):91–102. Exclusion Code: X2. [PubMed: 23322285]
178.
Lai LL, Sorkin AL. Cost benefit analysis of pharmaceutical care in a Medicaid population\M/from a budgetary perspective. J Manag Care Pharm. 1998;4(May-Jun):303–8. Exclusion Code: X6.
179.
Lai PS, Chua SS, Chan SP. Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates. J Clin Pharm Ther. 2012;37(5):536–43. Exclusion Code: X2. [PubMed: 22380577]
180.
Lam A. Practice innovations: Delivering medication therapy management services via videoconference interviews. Consultant pharmacist. 2011;(10):764–73. Exclusion Code: X4. [PubMed: 22005142]
181.
Lam A, Odegard PS, Gardner J. School of pharmacy-based medication therapy management program: development and initial experience. J Am Pharm Assoc (2003). 2012 May-Jun;52(3):398–404. Exclusion Code: X4. [PubMed: 22618981]
182.
Lam S, Ruby CM. Impact of an interdisciplinary team on drug therapy outcomes in a geriatric clinic. Am J Health Syst Pharm. 2005 Mar 15;62(6):626–9. Exclusion Code: X2. [PubMed: 15757885]
183.
LaMarr B, Valdez C, Driscoll K, et al. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm. 2010 Feb 15;67(4):290–4. Exclusion Code: X2. [PubMed: 20133534]
184.
Lambert-Kerzner A, Del Giacco EJ, Fahdi IE, et al. Patient-centered adherence intervention after acute coronary syndrome hospitalization. Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):571–6. Exclusion Code: X6. [PubMed: 22811499]
185.
Lapane KL, Hughes CM. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control. Ann Pharmacother. 2006 Sep;40(9):1522–6. Exclusion Code: X5. [PubMed: 16882872]
186.
Lapane KL, Hughes CM, Christian JB, et al. Evaluation of the fleetwood model of long-term care pharmacy. J Am Med Dir Assoc. 2011 Jun;12(5):355–63. Exclusion Code: X2. [PubMed: 21450170]
187.
Lau DT. Consumer medication management and error. Clin Ther. 2008 Nov;30(11):2156–8. Exclusion Code: X1. [PMC free article: PMC2748978] [PubMed: 19108803]
188.
Ledwidge M, Barry M, Cahill J, et al. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail. 2003;(3):381–9. (Structured abstract) Exclusion Code: X2. [PubMed: 12798838]
189.
Lee E, Braund R, Tordoff J. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. N Z Med J. 2009 Apr 24;122(1293):3566. Exclusion Code: X6. [PubMed: 19448788]
190.
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec 6;296(21):2563–71. Exclusion Code: X2. [PubMed: 17101639]
191.
Lee KL, Peng YL, Chou JL, et al. Economic evaluation of therapeutic drug monitoring services in renal transplant recipients treated with cyclosporine. Transplant Proc. 2000;(7):1801–6. (Structured abstract) Exclusion Code: X3. [PubMed: 11119944]
192.
Lee M, Kemp JA, Canning A, et al. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999 Oct 25;159(19):2312–6. Exclusion Code: X3. [PubMed: 10547171]
193.
Leikola SN, Virolainen J, Tuomainen L, et al. Comprehensive medication reviews for elderly patients: findings and recommendations to physicians. J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):630–3. Exclusion Code: X4. [PubMed: 23023843]
194.
Lemay G. Medication therapy management in community pharmacy practice. Med Health R I. 2012 Sep;95(9):281–2. Exclusion Code: X1. [PubMed: 23094424]
195.
Li X, Mao M, Ping Q. Effect of pharmaceutical care programs on glycemic control in patients with diabetes mellitus: a meta-analysis of randomized controlled trials. J Pharm Technol. 2010;(5):255–63. (Structured abstract) Exclusion Code: X2.
196.
Liang C. The Impact of Post-Discharge Medication Therapy Management (MTM) Encounters on Readmission Rate. Kaiser Permanente; Exclusion Code: X2.
197.
Libby EA, Laub JJ. Economic and clinical impact of a pharmacy-based antihypertensive replacement program in primary care. Am J Health Syst Pharm. 1997 Sep 15;54(18):2079–83. Exclusion Code: X2. [PubMed: 9377207]
198.
Lin KE, Lei EX, Chretien SD. Pharmacotherapy assessment and education for newly enrolled patients in a primary care clinic. ASHP Midyear Clinical Meeting. 2001;36(Dec) P-E. Exclusion Code: X3.
199.
Lingaratnam S, Aranda S, Pearce T, et al. A controlled before and after study to evaluate a patient and health professional partnership model towards effective medication reconciliation. J Oncol Pharm Pract. 2013 Mar;19(1):48–56. Exclusion Code: X4. [PubMed: 22849967]
200.
Linton A, Bacon TA, Trice S, et al. Results from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications. J Manag Care Pharm. 2010 Oct;16(8):578–92. Exclusion Code: X2. [PMC free article: PMC10438093] [PubMed: 20866163]
201.
Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care. 1992 Jul;30(7):646–58. Exclusion Code: X2. [PubMed: 1614233]
202.
Lobeck F, Traxler WT, Bobinet DD. The cost-effectiveness of a clinical pharmacy service in an outpatient mental health clinic. Hosp Community Psychiatry. 1989 Jun;40(6):643–5. Exclusion Code: X2. [PubMed: 2500390]
203.
Lu Z, Cao S, Chai Y, et al. Effectiveness of interventions for hypertension care in the community: a meta-analysis of controlled studies in China. DARE. 2012;(4) (Provisional abstract) Exclusion Code: X2. [PMC free article: PMC3416668] [PubMed: 22827968]
204.
Ma CB, Nakasato SK. Effectiveness of an educational program to improve patient understanding of and compliance with drug therapies used to treat HIV disease. ASHP Midyear Clinical Meeting. 1991;26(Dec) P-R. Exclusion Code: X2.
205.
Maack B, Miller DR, Johnson T, et al. Economic impact of a pharmacy resident in an assisted living facility-based medication therapy management program. Ann Pharmacother. 2008 Nov;42(11):1613–20. Exclusion Code: X4. [PubMed: 18940921]
206.
Malaeb DN, Aoun J. Physician community pharmacist collaborative care in diabetes management. 2011. P. Exclusion Code: X2.
207.
Martinez AS, Saef J, Paszczuk A, et al. Implementation of a pharmacist-managed heart failure medication titration clinic. Am J Health Syst Pharm. 2013 Jun 15;70(12):1070–6. Exclusion Code: X4. [PubMed: 23719886]
208.
McAdam-Marx C, Schaaf DT, Holtorf AP, et al. Systematic analysis of outcomes evaluations applied to drug management programs. Am J Manag Care. 2008 Nov;14(11 Suppl):SP36–45. Exclusion Code: X2. [PubMed: 18991480]
209.
McAllister D, Schommer JC, McAuley JW, et al. Comparison of skilled nursing and assisted living residents to determine potential benefits of pharmacist intervention. Consultant Pharmacist (USA). 2000;15(Nov):1110–6. Exclusion Code: X2.
210.
McCall N, Cromwell J, Urato C. Evaluation of Medicare Care Management for High Cost Beneficiaries (CMHCB) Demonstration: VillageHealth's Key to Better Health (KTBH). Baltimore, MD: Centers for Medicare & Medicaid Services; 2010. (Prepared by RTI International under CMS Contract No #500-00-0024/TO#25) Exclusion Code: X2.
211.
McCombs JS, Liu G, Shi J, et al. The Kaiser Permanente/USC Patient Consultation Study: change in use and cost of health care services. Am J Health Syst Pharm. 1998 Dec 1;55(23):2485–99. Exclusion Code: X2. [PubMed: 9853633]
212.
McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006 Feb;26(2):248–53. Exclusion Code: X2. [PubMed: 16466329]
213.
McDonough RP. Medication therapy management and collaborative practice: How to make it work. Drug Topics. 155:52. Exclusion Code: X1.
214.
McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. J Am Pharm Assoc (2003). 2003 Jul-Aug;43(4):511–8. Exclusion Code: X2. [PubMed: 12952316]
215.
McFarland M, Davis K, Wallace J, et al. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacotherapy. 2012 May;32(5):420–6. Exclusion Code: X2. [PubMed: 22488512]
216.
McIntosh K. Medicines management. Nurs Times. 2008 Nov 4-10;104(44):18–20. Exclusion Code: X1. [PubMed: 19014127]
217.
McKibbon KA, Lokker C, Handler SM, et al. The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):22–30. Exclusion Code: X2. [PMC free article: PMC3240758] [PubMed: 21852412]
218.
McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003 May-Jun;10(4):195–202. Exclusion Code: X2. [PubMed: 12851665]
219.
McMahan R. Medication therapy management services: assessing year 1, gauging year 2. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):680–1. Exclusion Code: X1. [PubMed: 17176682]
220.
Meindl CL, Duncan AL, Achusim LE, et al. Impact of a clinical pharmacist in an internal medicine resident clinic. ASHP Midyear Clinical Meeting. 1998;33(Dec) P-R. Exclusion Code: X4.
221.
Michaels NM, Jenkins GF, Pruss DL, et al. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc (2003). 2010 May-Jun;50(3):347–53. Exclusion Code: X4. [PubMed: 20452907]
222.
Michel B, Quelennec B, Andres E. Medication reconciliation practices and potential clinical impact of unintentional discrepancies. JAMA Intern Med. 2013 Feb 11;173(3):246–7. Exclusion Code: X2. [PubMed: 23400661]
223.
Midlov P, Bahrani L, Seyfali M, et al. The effect of medication reconciliation in elderly patients at hospital discharge. Int J Clin Pharm. 2012 Feb;34(1):113–9. Exclusion Code: X2. [PubMed: 22207271]
224.
Monte SV, Slazak EM, Albanese NP, et al. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):200–8. Exclusion Code: X4. [PubMed: 19289346]
225.
Mort J. Medication therapy management: a Medicare Part D benefit available to qualifying beneficiaries. S D Med. 2007 Mar;60(3):121. Exclusion Code: X1. [PubMed: 17455583]
226.
Mortimer C, Emmerton L, Lum E. The impact of an aged care pharmacist in a department of emergency medicine. J Eval Clin Pract. 2011 Jun;17(3):478–85. Exclusion Code: X3. [PubMed: 21040247]
227.
Motz J. The implementation of MTM in community pharmacies - Communication and planning are key factors for success. J Pharm Soc Wis. 2007;(SEP-OCT):11–2. Exclusion Code: X1.
228.
Mueller SK, Kripalani S, Stein J, et al. A toolkit to disseminate best practices in inpatient medication reconciliation: multi-center medication reconciliation quality improvement study (MARQUIS). Jt Comm J Qual Patient Saf. 2013 Aug;39(8):371–82. Exclusion Code: X2. [PubMed: 23991510]
229.
Mueller SK, Sponsler KC, Kripalani S, et al. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med. 2012 Jul 23;172(14):1057–69. Exclusion Code: X2. [PMC free article: PMC3575731] [PubMed: 22733210]
230.
Murphy P, Cocohoba J, Tang A, et al. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. Aids Patient Care STDS. 2012 Sep;26(9):526–31. Exclusion Code: X2. [PMC free article: PMC4088351] [PubMed: 22860900]
231.
Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007 May 15;146(10):714–25. Exclusion Code: X2. [PubMed: 17502632]
232.
Nau DP, Pacholski AM. Impact of pharmacy care services on patients' perceptions of health care quality for diabetes. J Am Pharm Assoc (2003). 2007 May-Jun;47(3):358–65. Exclusion Code: X4. [PubMed: 17510030]
233.
Nguyen J. Evaluating the Medication Therapy Management Program Impact on Hospital and ED Visits. Kaiser Permanente; pp. 1–34. Exclusion Code: X7.
234.
Nguyen J, Matsuoka B, Morodomi L, et al. Evaluating the Medication Therapy Management Program impact. CA J Health-Sys Pharm. 2011;23:11. Exclusion Code: X8.
235.
Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010(7) CD000336. Exclusion Code: X6. [PMC free article: PMC7087444] [PubMed: 20614422]
236.
Nola KM, Gourley DR, Portner TS, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc (Wash). 2000;(2):166–73. Exclusion Code: X2. [PubMed: 10730020]
237.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487–97. Exclusion Code: X1. [PubMed: 16079372]
238.
Oyetayo OO, James C, Martinez A, et al. The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes. J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):623–6. Exclusion Code: X4. [PubMed: 21896461]
239.
Packard K, Herink M, Kuhlman P. Pharmacist's role in an interdisciplinary cardiac rehabilitation team. J Allied Health. 2012 Fall;41(3):113–7. 7a, 7b. Exclusion Code: X4. [PubMed: 22968772]
240.
Padiyara RS, Rabi SM. Physician perceptions of pharmacist provision of outpatient medication therapy management services. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):660, 3. Exclusion Code: X4. [PubMed: 17176679]
241.
Pakes GE. Group medication counseling conducted by a pharmacist for severely disturbed clients. Hosp Community Psychiatry. 1979 Apr;30(4):237–8. Exclusion Code: X2. [PubMed: 422130]
242.
Parks PM. A patient medication counseling group in an adult psychiatric facility. Hosp Pharm. 1977 Feb;12(2):63–4. Exclusion Code: X4. [PubMed: 10305432]
243.
Patel P, Roberts S, Cooper S, et al. Evaluation of Medication Therapy Management Program in a Health Maintenance Organization. Kaiser Permanente; pp. 1–13. Exclusion Code: X4.
244.
Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5 CD008165. Exclusion Code: X2. [PubMed: 22592727]
245.
Pecora PG, Flint NB, Aleman MA. Improving disease control in patients with hypertension and/or diabetes mellitus with the implementation of ambulatory clinical pharmacy services. ASHP Midyear Clinical Meeting. 1998;33(Dec) P-E. Exclusion Code: X2.
246.
Perera PN, Guy MC, Sweaney AM, et al. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). J Manag Care Pharm. 2011 Jun;17(5):345–54. Exclusion Code: X4. [PMC free article: PMC5013826] [PubMed: 21657804]
247.
Persell SD, Eder M, Friesema E, et al. EHR-based medication support and nurse-led medication therapy management: rationale and design for a three-arm clinic randomized trial. J Am Heart Assoc. 2013 Oct;2(5):e000311. Exclusion Code: X6. [PMC free article: PMC3835237] [PubMed: 24157649]
248.
Petty DR, Zermansky AG, Raynor DK, et al. Clinical medication review by a pharmacist of elderly patients on repeat medications in general practice - Pharmacist interventions and review outcomes. Int J Pharm Pract. 2002;(1):39–45. Exclusion Code: X5.
249.
Pickard AS, Johnson JA, Farris KB. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother. 1999 Nov;33(11):1167–72. Exclusion Code: X2. [PubMed: 10573313]
250.
Pinto SL, Bechtol RA, Partha G. Evaluation of outcomes of a medication therapy management program for patients with diabetes. :519. Exclusion Code: X4. [PubMed: 22825233]
251.
Pinto SL, Kumar J, Partha G, et al. Pharmacist-Provided Medication Therapy Management (MTM) Program Impacts Outcomes for Employees With Diabetes. Popul Health Manag. 2013 Jul 12 Exclusion Code: X4. [PubMed: 23848476]
252.
Pinto SL, Kumar J, Partha G, et al. Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management. Clinicoecon Outcomes Res. 2013;5:153–9. Exclusion Code: X4. [PMC free article: PMC3629878] [PubMed: 23610526]
253.
Ponnusankar S, Surulivelrajan M, Anandamoorthy N, et al. Assessment of impact of medication counseling on patients' medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns. 2004 Jul;54(1):55–60. Exclusion Code: X2. [PubMed: 15210260]
254.
Powers MF. Recently approved medicare provisions for prescription drugs and medication management services. J Pharm Tech. 2005;21(Feb):63–8. Exclusion Code: X2.
255.
Raimondi GA, Menga G, Botas C, et al. Decline of outpatient asthma management in Argentina. Respirology. 2008 Jan;13(1):134–7. Exclusion Code: X2. [PubMed: 18197924]
256.
Reinke T. Medication therapy management program in N.C. saves $13 million. Manag Care. 2011 Oct;20(10):17–8. Exclusion Code: X1. [PubMed: 22111478]
257.
Rennke S, Nguyen OK, Shoeb MH, et al. Hospital-initiated transitional care interventions as a patient safety strategy: a systematic review. DARE. 2013;(4):433–40. (Structured abstract) Exclusion Code: X2. [PubMed: 23460101]
258.
Riley D, Dodson P. Medicine management for the elderly. Tex Hosp. 1983 Apr;38(11):20. Exclusion Code: X1. [PubMed: 10317312]
259.
Roberts S, Gainsbrugh R. Medication therapy management and collaborative drug therapy management. J Manag Care Pharm. 2010 Jan-Feb;16(1):67–8. Exclusion Code: X6. [PMC free article: PMC10437445] [PubMed: 20044847]
260.
Rodgers S, Avery AJ, Meechan D, et al. Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs. Br J Gen Pract. 1999 Sep;49(446):717–20. Exclusion Code: X2. [PMC free article: PMC1313499] [PubMed: 10756613]
261.
Ross LA, Bloodworth LS. Patient-centered health care using pharmacist-delivered medication therapy management in rural Mississippi. JAPhA. 52:802. Exclusion Code: X4. [PubMed: 23229968]
262.
Roughead EE, Barratt JD, Ramsay E, et al. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther. 2011 Feb;36(1):27–32. Exclusion Code: X2. [PubMed: 21108651]
263.
Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract. 2005;(1):53–70. (Structured abstract) Exclusion Code: X3.
264.
Rozenfeld V, Pflomm J, Singh KK, et al. Assessing the impact of medication consultations with a Medication Event Monitoring System. Hosp Pharm. 1999;(5):539–49. Exclusion Code: X2.
265.
Rucker NL. Medicare Part D's Medication Therapy Management: Shifting from Neutral to Drive. AARP Public Policy Institute; Washington, DC: 2012. Exclusion Code: X1.
266.
Sadler MA, Force RW. Pharmacy services in an ambulatory FFS setting can increase physician revenue. Formulary (USA). 2002;37(Feb):97–01. Exclusion Code: X2.
267.
Saez-Benito L, Fernandez-Llimos F, Feletto E, et al. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013 Jul;42(4):442–9. Exclusion Code: X2. [PubMed: 23676212]
268.
Saini B, Filipovska J, Bosnic-Anticevich S, et al. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health. 2008 Apr;16(2):100–8. Exclusion Code: X2. [PubMed: 18318852]
269.
Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;(11):1954–60. (Structured abstract) Exclusion Code: X2. [PubMed: 15479780]
270.
Salvador CH, Ruiz-Sanchez A, Gonzalez de Mingo MA, et al. Evaluation of a telemedicine-based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy. IEEE Trans Inf Technol Biomed. 2008 Nov;12(6):696–706. Exclusion Code: X2. [PubMed: 19000948]
271.
Sando KR, Elliott J, Stanton ML, et al. An educational tool for teaching medication history taking to pharmacy students. Am J Pharm Educ. 2013 Jun 12;77(5):105. Exclusion Code: X2. [PMC free article: PMC3687116] [PubMed: 23788816]
272.
Schnipper JL, Roumie CL, Cawthon C, et al. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study. Circulation. 2010;(2):212–9. Exclusion Code: X7. [PMC free article: PMC3021350] [PubMed: 20233982]
273.
Schroeder SD. Quality focus: medication therapy management services. A multi-state collaborative. S D Med. 2007 Dec;60(12):499. Exclusion Code: X4. [PubMed: 18232257]
274.
Schulz M. Pharmacist care for reactive airway disease. JAMA. 2003 Mar 5;289(9):1104. author reply 5-6. Exclusion Code: X1. [PubMed: 12622576]
275.
Schulz M, Verheyen F, Muhlig S, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001 Jun;41(6):668–76. Exclusion Code: X2. [PubMed: 11402636]
276.
Schulz RM, Porter C, Lane M, et al. Impact of a medication management system on nursing home admission rate in a community-dwelling nursing home-eligible Medicaid population. Am J Geriatr Pharmacother. 2011 Feb;9(1):69–79. Exclusion Code: X2. [PubMed: 21459310]
277.
Scott A, Tinelli M, Bond C. Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives. Pharmacoeconomics. 2007;25(5):397–411. Exclusion Code: X2. [PubMed: 17488138]
278.
Shah C, Coyne T. Medicines management programme for non-medical prescribers. Nurs Manag (Harrow). 2012 Dec;19(8):34–7. Exclusion Code: X2. [PubMed: 23285791]
279.
Shillam CR, Orton VJ, Waring D, et al. Faith community nurses & brown bag events help older adults manage meds. J Christ Nurs. 2013 Apr-Jun;30(2):90–6. Exclusion Code: X4. [PubMed: 23607155]
280.
Simon GE, Ludman EJ, Operskalski BH. Randomized trial of a telephone care management program for outpatients starting antidepressant treatment. Psychiatr Serv. 2006 Oct;57(10):1441–5. Exclusion Code: X2. [PubMed: 17035563]
281.
Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001 May;21(5):627–35. Exclusion Code: X2. [PubMed: 11349751]
282.
Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999 Dec;33(12):1336–55. Exclusion Code: X4. [PubMed: 10630834]
283.
Sklenicka JM, Proffitt LS, Dare D. The role of a geriatric clinical pharmacist in improving medication safety in outpatient clinics. ASHP Midyear Clinical Meeting. 2005;40 P-D. Exclusion Code: X4.
284.
Smith CP, Christensen DB. Identification and clarification of drug therapy problems by Indian health service pharmacists. Ann Pharmacother. 1996 Feb;30(2):119–24. Exclusion Code: X4. [PubMed: 8835041]
285.
Smith DH, Fassett WE, Christensen DB. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc (Wash). 1999 Sep-Oct;39(5):650–7. Exclusion Code: X2. [PubMed: 10533346]
286.
Smith SR, Catellier DJ, Conlisk EA, et al. Effect on health outcomes of a community-based medication therapy management program for seniors with limited incomes. Am J Health Syst Pharm. 2006 Feb 15;63(4):372–9. Exclusion Code: X2. [PubMed: 16452523]
287.
Smith SR, Clancy CM. Medication therapy management programs: forming a new cornerstone for quality and safety in medicare. Am J Med Qual. 2006 Jul-Aug;21(4):276–9. Exclusion Code: X1. [PubMed: 16849785]
288.
Soller RW, Vogt E. Positioning patient counselling as a measurable cornerstone of medication therapy management. Int J Pharm Pract. 2010 Oct;18(5):249–51. Exclusion Code: X1. [PubMed: 20840679]
289.
Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;(5):574–85. Exclusion Code: X2. [PubMed: 9782691]
290.
Solow B. Medication therapy management--not just for seniors anymore. Manag Care. 2009 Oct;18(10):7. Exclusion Code: X1. [PubMed: 19902682]
291.
Sperling S, Neal K, Hales K, et al. A quality improvement project to reduce falls and improve medication management. Home Health Care Serv Q. 2005;24(1-2):13–28. Exclusion Code: X3. [PubMed: 16236656]
292.
Spooner JJ. Medication therapy management programs: when will the outcomes come out? J Manag Care Pharm. 2007 Apr;13(3):276–7. Exclusion Code: X1. [PMC free article: PMC10437893] [PubMed: 17407394]
293.
Stang P, Morris L, Kempf J, et al. The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events. Am J Ther. 2007 Jan-Feb;14(1):30–40. Exclusion Code: X2. [PubMed: 17303973]
294.
Stebbins MR, Kaufman DJ, Lipton HL. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services. J Manag Care Pharm. 2005 May;11(4):333–41. Exclusion Code: X4. [PMC free article: PMC10438308] [PubMed: 15871644]
295.
Stefanacci RG, Haimowitz D. Medication management in assisted living. Geriatr Nurs. 2012 Jul-Aug;33(4):304 e1–12. Exclusion Code: X1. [PubMed: 22841458]
296.
Stell R, Bonollo M, Fiddes K, et al. Successful integration of a clinical pharmacist into a disease management unit. J Pharm Pract Res. 2008;38(Feb):132–6. Exclusion Code: X2.
297.
Stemer G, Lemmens-Gruber R. Clinical pharmacy services and solid organ transplantation: a literature review. Pharm World Sci. 2010;(1):7–18. (Structured abstract) Exclusion Code: X2. [PubMed: 20012363]
298.
Stergachis A, Gardner JS, Anderson MT, et al. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):743–52. Exclusion Code: X3. [PubMed: 12269709]
299.
Stewart S, Pearson S, Luke CG, et al. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc. 1998;(2):174–80. (Structured abstract) Exclusion Code: X2. [PubMed: 9475445]
300.
Stockl KM, Shin JS, Gong S, et al. Improving patient self-management of multiple sclerosis through a disease therapy management program. Am J Manag Care. 2010 Feb;16(2):139–44. Exclusion Code: X2. [PubMed: 20148619]
301.
Stockl KM, Tjioe D, Gong S, et al. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program. J Manag Care Pharm. 2008 Jul-Aug;14(6):532–40. Exclusion Code: X5. [PMC free article: PMC10437609] [PubMed: 18693777]
302.
Strand LM, Cipolle RJ, Morley PC, et al. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987–4001. Exclusion Code: X4. [PubMed: 15579084]
303.
Stratton TP, Cernohous T, Hager K, et al. College of pharmacy-based medication therapy management program for a university system. J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):653–60. Exclusion Code: X4. [PubMed: 23023847]
304.
Strom BL, Hennessy S. Pharmacist care and clinical outcomes for patients with reactive airways disease. JAMA. 2002 Oct 2;288(13):1642–3. Exclusion Code: X1. [PubMed: 12350196]
305.
Summers KH. Medication therapy management versus drug regimen review. J Manag Care Pharm. 2007 Jan-Feb;13(1):68–9. Exclusion Code: X1. [PMC free article: PMC10438360] [PubMed: 17269840]
306.
Swims MP, Reed P. A pharmacotherapy clinic in a neurologic practice. J Pharm Tech. 2006;22(May):254–60. Exclusion Code: X4.
307.
Tarn YH, Chou SF, Wang TY. Drug regimen review at nursing homes in Taiwan (CPS-O-013). Int Pharm Fed. 2002;62:78. Exclusion Code: X2.
308.
Taylor J, Davies P. The medicines management needs of carers during an episode of mental health crisis. J Psychiatr Ment Health Nurs. 2012 Mar;19(2):190–2. Exclusion Code: X1. [PubMed: 22070543]
309.
Tett SE, Higgins GM, Armour CL. Impact of pharmacist interventions on medication management by the elderly: a review of the literature. Ann Pharmacother. 1993 Jan;27(1):80–6. Exclusion Code: X2. [PubMed: 8431627]
310.
Thomas MC. A Practical Approach to Medication Reconciliation by Pharmacists in a Community Hospital Emergency Department. :41. Exclusion Code: X1.
311.
Thomas R, Kilbey C. Complex medicines management. Nurs Times. 2011 Mar 1-7;107(8):20–2. Exclusion Code: X4. [PubMed: 21667662]
312.
Thompson CA. State-paid medication therapy management services succeed. Am J Health Syst Pharm. 2008 Mar 15;65(6):490, 3, 8. Exclusion Code: X1. [PubMed: 18319489]
313.
Tinelli M, Bond C, Blenkinsopp A, et al. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007 Dec;41(12):1962–70. Exclusion Code: X2. [PubMed: 17971403]
314.
Tinelli M, Ryan M, Bond C, et al. Valuing benefits to inform a clinical trial in pharmacy: do differences in utility measures at baseline affect the effectiveness of the intervention? Pharmacoeconomics. 2013 Feb;31(2):163–71. Exclusion Code: X2. [PubMed: 23329427]
315.
Touchette DR. Improving adherence in the community and clinic pharmacy settings: an emerging opportunity. Pharmacotherapy. 2010 May;30(5):425–7. Exclusion Code: X1. [PubMed: 20411993]
316.
Trask SJ, Szabo SA. Polypharmacy intervention program in a tertiary care VA medical center. ASHP Midyear Clinical Meeting. 1991;26(Dec) P-R. Exclusion Code: X2.
317.
Traynor K. Maryland School of Pharmacy, XLHealth team up on medication management project. Am J Health Syst Pharm. 2010 Jun 1;67(11):868, 70. Exclusion Code: X1. [PubMed: 20484207]
318.
Triller DM, Hamilton RA. Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm. 2007 Nov 1;64(21):2244–9. Exclusion Code: X7. [PubMed: 17959576]
319.
Truong AC. Evaluating the impact of a medication teaching clinic in a hospital based outpatient pharmacy. ASHP Midyear Clinical Meeting. 2006;41 Exclusion Code: X4.
320.
Trygstad TK, Christensen D, Garmise J, et al. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative. J Manag Care Pharm. 2005 Sep;11(7):575–83. Exclusion Code: X2. [PMC free article: PMC10438263] [PubMed: 16137215]
321.
Trygstad TK, Christensen DB, Wegner SE, et al. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting. Clin Ther. 2009 Sep;31(9):2018–37. Exclusion Code: X2. [PubMed: 19843492]
322.
Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002 May 27;162(10):1149–55. Exclusion Code: X2. [PubMed: 12020186]
323.
VanHaaren A. Pharmaceutical care in a multi-site medical group practice: reaching goals in the treatment of hyperlipidemia and diabetes. ASHP Midyear Clinical Meeting. 2006;41(Dec) Exclusion Code: X4.
324.
Vinks TH, Egberts TC, de Lange TM, et al. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123–33. Exclusion Code: X2. [PubMed: 19220069]
325.
Viswanathan M, Golin CE, Jones CD, et al. Evidence Report No. 208. Rockville, MD: Agency for Healthcare Research and Quality; Sep, 2012. Medication Adherence Interventions: Comparative Effectiveness. Closing the Quality Gap: Revisiting the State of the Science. www​.effectivehealthcare​.ahrq.gov/reports/final.cfm. Exclusion Code: X1.
326.
Vuong T, Marriott JL, Kong DCM, et al. Implementation of a community liaison pharmacy service: a randomised controlled trial. Int J Pharm Pract. 2008;(3):127–35. Exclusion Code: X2.
327.
Walberg SJ, Haight R. Discharge follow-up with a pharmacist study: Incorporating pharmacist-provided discharge education and medication reconciliation with an outpatient follow-up service for patients with psychiatric illness discharged to an outpatient day treatment program. J Pharm Pract. 2008;21(Jan):75–6. Exclusion Code: X4.
328.
Walker S, Willey CW. Impact on drug costs and utilization of a clinical pharmacist in a multisite primary care medical group. J Manag Care Pharm. 2004 Jul-Aug;10(4):345–54. Exclusion Code: X2. [PMC free article: PMC10437772] [PubMed: 15298532]
329.
WALTON T, HOLLOWAY KP, KNAUSS MD. Pharmacist-managed anemia program in an outpatient hemodialysis population. Hosp Pharm. 2005;40(12):1051–6. Exclusion Code: X2.
330.
Ward MA, Xu Y. Pharmacist-provided telephonic medication therapy management in an MAPD plan. Am J Manag Care. 2011 Oct;17(10):e399–409. Exclusion Code: X2. [PubMed: 21999720]
331.
Watkins JL, Landgraf A, Barnett CM, et al. Evaluation of pharmacist-provided medication therapy management services in an oncology ambulatory setting. J Am Pharm Assoc (2003). 2012 Mar-Apr;52(2):170–4. Exclusion Code: X4. [PMC free article: PMC3868215] [PubMed: 22370379]
332.
Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002 Oct 2;288(13):1594–602. Exclusion Code: X2. [PubMed: 12350190]
333.
Weinhandl ED, Arneson TJ, St Peter WL. Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report. Am J Kidney Dis. 2013 Sep;62(3):557–67. Exclusion Code: X2. [PubMed: 23597860]
334.
Wessell AM, Ornstein SM, Jenkins RG, et al. Medication Safety in Primary Care Practice: results from a PPRNet quality improvement intervention. Am J Med Qual. 2013 Jan-Feb;28(1):16–24. Exclusion Code: X2. [PubMed: 22679129]
335.
Westfall GR, Narducci WA. A community-pharmacy-based callback program for antibiotic therapy. J Am Pharm Assoc (Wash). 1997 May-Jun;NS37(3):330–4. Exclusion Code: X2. [PubMed: 9170810]
336.
While A. Making the most of good medicines management. Br J Community Nurs. 2007 Sep;12(9):434. Exclusion Code: X1. [PubMed: 18026009]
337.
White B, Truax D. The long and winding road. Arriving at safe medication management in LTC setting. Adv Nurse Pract. 2007 Sep;15(9):28–35. quiz -6. Exclusion Code: X1. [PubMed: 19998897]
338.
Wilk JE, West JC, Rae DS, et al. Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients. Psychiatr Serv. 2008 Jan;59(1):34–9. Exclusion Code: X2. [PubMed: 18182537]
339.
Williams A. Medicine management. Nurs Mirror. 1984 Oct 3;159(12):i–iii. vi. Exclusion Code: X1. [PubMed: 6567175]
340.
Williams BR, Lopez S. Reaching the homebound elderly: the Prescription Intervention and Lifelong Learning (PILL) program. Home Health Care Serv Q. 2005;24(1-2):61–72. Exclusion Code: X4. [PubMed: 16236659]
341.
Williams T, Acton C, Hicks RW. Deploying med reconciliation. Nurs Manage. 2008 Apr;39(4):54–7. Exclusion Code: X1. [PubMed: 18391828]
342.
Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995 Nov;160(11):561–4. Exclusion Code: X2. [PubMed: 8538891]
343.
Wilson J. Breaking down barriers. Am Pharm. 2005;127(Sep):24–6. Exclusion Code: X1.
344.
Wolfe SC, Schirm V. Medication counseling for the elderly: effects on knowledge and compliance after hospital discharge. Geriatr Nurs. 1992 May-Jun;13(3):134–8. Exclusion Code: X2. [PubMed: 1319935]
345.
Wong E. CDTM and smoking cessation. Hosp Pharm. 1999;34(Nov):1295–303. Exclusion Code: X1.
346.
Wong MC, Kong AP, So WY, et al. Pharmacoepidemiological profiles of oral hypoglycemic agents among 28,773 Chinese patients with diabetes. Diabetes Res Clin Pract. 2012 Jun;96(3):319–25. Exclusion Code: X2. [PubMed: 22305941]
347.
Wu JC, Chin M, Pitcher K, et al. Identifying hospitalization risk factors to prioritize medication therapy management enrollment. CA J Health-Sys Pharm. 22:19. Exclusion Code: X2.
348.
Yamamura K, Osada T, Yano K, et al. Evaluation of pharmacist-managed anticoagulation classroom. ASHP Midyear Clinical Meeting. 2006;41(Dec) Exclusion Code: X2.
349.
Yeoh TT, Si P, Chew L. The impact of medication therapy management in older oncology patients. Support Care Cancer. 2013 May;21(5):1287–93. Exclusion Code: X4. [PubMed: 23179492]
350.
Young D. Pharmaceutical case management helps Iowa Medicaid patients. Am J Health Syst Pharm. 2003 Mar 1;60(5):414, 6. Exclusion Code: X1. [PubMed: 12635443]
351.
Zagaria MA. Medication therapy management services. US Pharmacist (USA). 2004;30(Apr):35–42. Exclusion Code: X1.
352.
Zarowitz BJ, Stebelsky LA, Muma BK, et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005 Nov;25(11):1636–45. Exclusion Code: X4. [PubMed: 16232025]
353.
Zellmer WA. Collaborative drug therapy management. Am J Health Syst Pharm. 1995 Aug 1;52(15):1732. Exclusion Code: X1. [PubMed: 7583839]
354.
Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001 Dec 8;323(7325):1340–3. Exclusion Code: X2. [PMC free article: PMC60673] [PubMed: 11739221]
355.
Zermansky AG, Petty DR, Raynor DK, et al. Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. Health Technol Assess. 2002;6(20):1–86. Exclusion Code: X2. [PubMed: 12234455]
356.
Zierler-Brown S, Coll RE, Llewellyn K. Implementation and evaluation of a pharmacist-managed ambulatory, indigent care practice, focused on cardiovascular disease (CVD) prevention and management. ASHP Midyear Clinical Meeting. 2005;40 P-R. Exclusion Code: X4.
357.
Zillich AJ, Jaynes HA, Snyder ME, et al. Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients. Med Care. 2012 Jun;50(6):485–93. Exclusion Code: X2. [PMC free article: PMC4126258] [PubMed: 22498687]
358.
Zillich AJ, Sutherland JM, Kumbera PA, et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med. 2005 Dec;20(12):1091–6. Exclusion Code: X2. [PMC free article: PMC1490290] [PubMed: 16423096]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.1M)

Other titles in these collections

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...